HANSOH PHARMAC Ownership

3KY Stock  EUR 2.24  0.06  2.75%   
HANSOH PHARMAC HD 00001 has a total of 5.92 Billion outstanding shares. HANSOH PHARMAC HD retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.92 (percent) of HANSOH PHARMAC outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HANSOH PHARMAC HD 00001. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

HANSOH Stock Ownership Analysis

About 82.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 8th of September 2022. Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals and active pharmaceutical ingredients in the Peoples Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd. HANSOH PHARMAC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11645 people. For more info on HANSOH PHARMAC HD 00001 please contact Huijuan Zhong at 86 21 3177 3517 or go to http://www.hspharm.com.

HANSOH PHARMAC Outstanding Bonds

HANSOH PHARMAC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. HANSOH PHARMAC HD uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most HANSOH bonds can be classified according to their maturity, which is the date when HANSOH PHARMAC HD 00001 has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in HANSOH Stock

HANSOH PHARMAC financial ratios help investors to determine whether HANSOH Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HANSOH with respect to the benefits of owning HANSOH PHARMAC security.